Cancer Incidence - Liver and Intrahepatic Bile Duct
Summary Indicator Report Data View Options
Incidence of Cancer of the Liver and Intrahepatic Bile Duct by County, New Mexico, 2017-2021
Why Is This Important?
Primary liver cancer (cancer that starts in the liver) accounts for over 2% of all new cancer cases and 5% of all cancer deaths in the U.S, which represents approximately 41,260 cases and 30,520 deaths. The five-year survival rate is 21%. Disease risk among males is about 3 times higher than that in females, reflecting a gender difference in risk factors that include alcohol abuse, chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), exposure to aflatoxin, and obesity. HBV and HCV can be spread from person to person through sharing contaminated needles (such as in drug use) or unprotected sex. Given these major risk factors, many cases of liver cancer are considered to be preventable.
Definition
Liver and intrahepatic bile duct cancer incidence refers to the number of persons newly diagnosed with liver and intrahepatic bile duct cancer during a specified time period. Measures include 1) age-adjusted incidence rate of liver and intrahepatic bile duct cancer (adjusted by the direct method to the 2000 US standard population and 2) age-adjusted incidence rates by race/ethnicity. All rates are expressed per 100,000 persons.
Data Sources
- New Mexico Population Estimates: University of New Mexico, Geospatial and Population Studies (GPS) Program.
(http://gps.unm.edu/) - New Mexico Tumor Registry
(https://nmtrweb.unm.edu/) - Cancer Surveillance, Epidemiology, and End Results (SEER) Program
(http://www.seer.cancer.gov)
How the Measure is Calculated
| Numerator: | The number of liver and intrahepatic bile duct cancer cases newly diagnosed in New Mexico residents within a specified time period. The data are based on the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program incidence site recode for liver cancer (SEER Recode B 21071, 21072); ICD-O-3 codes: primary sites C220, C221; excludes histologies: 9590-9989, and 9140; Malignant cases: ICD behavior code 3. |
| Denominator: | The estimated population of New Mexico residents within a specified time period. |
How Are We Doing?
New Mexico has averaged about 277 new cases of liver cancer each year between 2017 and 2021. Since 2001, age-adjusted rates of liver cancer in New Mexico have increased by almost 40%, which is less than the national increase of approximately 60%.
How Do We Compare With the U.S.?
Age-adjusted rates of liver cancer in NM remain higher than the national rate (9.7 vs 9.5 per 100,000 population, respectively). Nationally, liver cancer is more common in men than women, and among Asian/Pacific Islander and American Indian/Alaska Native populations. This pattern is mirrored in New Mexico.
Evidence-based Practices
https://health.gov/healthypeople/objectives-and-data/browse-objectives/cancer/evidence-based-resources
Other Objectives
CDC Environmental Public Health Tracking, Nationally Consistent Data and Measures (EPHT NCDM)
More Resources
SEER Cancer Stat Facts: Liver and Intrahepatic Bile Duct Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/livibd.html
Health Program Information
https://nmtracking.doh.nm.gov/health/cancer/CancerConcernsWorkgroup.html